Abacus Planning Group’s Pacific Biosciences PACB Stock Holding History

Abacus Planning Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.1K	Hold	51,238	–	–	0.01%	256
2026 Q1	$67.6K	Sell	51,238 -48,762	-49%	-$87.2K	0.01%	262
2025 Q4	$187K	Hold	100,000	–	–	0.02%	254
2025 Q3	$128K	Hold	100,000	–	–	0.02%	249
2025 Q2	$124K	Hold	100,000	–	–	0.02%	237
2025 Q1	$118K	Hold	100,000	–	–	0.02%	223
2024 Q4	$183K	Hold	100,000	–	–	0.03%	209
2024 Q3	$170K	Hold	100,000	–	–	0.03%	205
2024 Q2	$137K	Hold	100,000	–	–	0.03%	203
2024 Q1	$375K	Hold	100,000	–	–	0.07%	129
2023 Q4	$981K	Hold	100,000	–	–	0.21%	71
2023 Q3	$835K	Hold	100,000	–	–	0.2%	77
2023 Q2	$1.33M	Sell	100,000 -20,000	-17%	-$243K	0.32%	45
2023 Q1	$1.39M	Hold	120,000	–	–	0.36%	41
2022 Q4	$982K	Sell	120,000 -20,000	-14%	-$172K	0.27%	59
2022 Q3	$813K	Hold	140,000	–	–	0.25%	64
2022 Q2	$619K	Hold	140,000	–	–	0.18%	85
2022 Q1	$1.27M	Sell	140,000 -15,000	-10%	-$173K	0.34%	51
2021 Q4	$3.17M	Sell	155,000 -25,000	-14%	-$603K	0.85%	22
2021 Q3	$4.6M	Hold	180,000	–	–	1.46%	13
2021 Q2	$6.29M	Hold	180,000	–	–	1.92%	11
2021 Q1	$6M	Sell	180,000 -220,000	-55%	-$7.7M	1.92%	11
2020 Q4	$10.4M	Sell	400,000 -302,937	-43%	-$5.15M	3.2%	8
2020 Q3	$6.94M	Buy	+702,937	New	+$4.05M	2.53%	9

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Abacus Planning Group's PACB Position: Q2 2026 in Review

Abacus Planning Group held its Pacific Biosciences (PACB) position steady in Q2 2026 at 51,238 shares worth $86.1K. The position accounts for 0.01% of the portfolio, ranked #256.

Abacus Planning Group first reported a position in PACB in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.4M in Q4 2020. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Abacus Planning Group held 51,238 shares of Pacific Biosciences worth $86.1K as of Q2 2026.
Abacus Planning Group left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up 0.01% of Abacus Planning Group's portfolio in Q2 2026, its #256 holding.
Abacus Planning Group first reported a position in Pacific Biosciences in Q3 2020 and has held it in 24 quarters since.
Abacus Planning Group's Pacific Biosciences position peaked at $10.4M in Q4 2020.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Abacus Planning Group's 13F filing for Q2 2026, filed 20 Jul 2026.